PUMA pathway is a weak link in breast cancer metastasis

December 11, 2017, JCI Journals

Substantial advancements have improved the success of chemotherapy, radiation, and surgical treatments for primary breast cancers. However, breast cancer that has spread, or metastasized, to other parts of the body remains a challenge to cure. It is difficult to predict whether a tumor will recur and metastasize, and uncertainty can lead to inadequate or overaggressive treatment.

The cells that initiate metastasis often resemble , a population of that enable development during adulthood. During pregnancy, hormonal signaling activates healthy stem cells, which initiate mammary gland remodeling that supports breast milk production. Now, a new study from Jay Desgrosellier's lab at UCSD has used the activation signature of mammary stem cells to identify vulnerabilities in stem-like metastasis-initiating cells.

In a study published this week in the JCI, Sun et al. report that low-level expression of a protein called PUMA (p53-upregulated modulator of apoptosis) distinguishes stem-like cells in cancer patients who experienced tumor recurrence during a 10-year follow-up period. The cells' ability to suppress PUMA levels was critical to their survival-enhancing PUMA expression selectively depleted stem-like properties and reduced metastasis, whereas reducing PUMA restored metastasis in cultured cells.

Together, these findings expose a possible Achilles heel in aggressive breast cancers that may enable earlier identification and better targeting of metastases. Present limitations in the ability to predict and eliminate aggressive cancer cells likely contribute to the majority of deaths from , but the development of adjuvant approaches that exploit their weaknesses may greatly improve disease outcomes.

Explore further: Researchers identify oestrogen receptor stem cells in the mammary gland.

More information: Qi Sun et al, Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis, Journal of Clinical Investigation (2017). DOI: 10.1172/JCI93707

Related Stories

Researchers identify oestrogen receptor stem cells in the mammary gland.

August 16, 2017
One of the key questions in stem cell and cancer biology is to understand the cellular hierarchy governing tissue development and maintenance and the cancer cell of origin. In a study published in Cell Reports, researchers ...

Fighting cancer: Natural and synthetic progestin therapies in post-menopausal women help breast cancer grow and spread

July 12, 2017
Hormone replacement therapies, or medications containing female hormones that substitute those no longer produced by the body, often are prescribed to reduce the effects of menopausal symptoms in women. Research has indicated ...

MicroRNA molecule may serve as biomarker, target for brain metastases in breast cancer patients

February 5, 2013
Researchers have identified two molecules that could potentially serve as biomarkers in predicting brain metastases in patients with breast cancer, according to data published in Cancer Research, a publication of the American ...

How breast cancer usurps the powers of mammary stem cells

August 11, 2014
During pregnancy, certain hormones trigger specialized mammary stem cells to create milk-producing cells essential to lactation. Scientists at the University of California, San Diego School of Medicine and Moores Cancer Center ...

ONC201 may inhibit cancer stem cell self-renewals by altering their gene expression

August 2, 2017
ONC201 may inhibit cancer stem cell self-renewals by altering their gene expression, according to a study published August 2, 2017 in the open-access journal PLOS ONE by Varun Vijay Prabhu from Oncoceutics, Inc., USA and ...

Study identifies RNA molecule that shields breast cancer stem cells from immune system

May 22, 2017
Researchers from Princeton University's Department of Molecular Biology have identified a small RNA molecule that helps maintain the activity of stem cells in both healthy and cancerous breast tissue. The study, which will ...

Recommended for you

Scientists develop 'world first' melanoma blood test

July 18, 2018
Australian researchers said Wednesday they have developed a blood test for melanoma in its early stages, calling it a "world first" breakthrough that could save many lives.

Early supper associated with lower risk of breast and prostate cancer

July 18, 2018
Having an early supper or leaving an interval of at least two hours before going to bed are both associated with a lower risk of breast and prostate cancer. Specifically, people who take their evening meal before 9 p.m. or ...

Magnetized wire could be used to detect cancer in people, scientists report

July 16, 2018
A magnetic wire used to snag scarce and hard-to-capture tumor cells could prove to be a swift and effective tactic for early cancer detection, according to a study by researchers at the Stanford University School of Medicine.

Researchers suggest new treatment for rare inherited cancers

July 16, 2018
Studying two rare inherited cancer syndromes, Yale Cancer Center (YCC) scientists have found the cancers are driven by a breakdown in how cells repair their DNA. The discovery, published today in Nature Genetics, suggests ...

Researchers map 'family trees' of acute myeloid leukemia

July 16, 2018
For the first time, a team of international researchers has mapped the family trees of cancer cells in acute myeloid leukaemia (AML) to understand how this blood cancer responds to a new drug, enasidenib. The work also explains ...

Scientists sharpen the edges of cancer chemotherapy with CRISPR

July 13, 2018
Tackling unsolved problems is a cornerstone of scientific research, propelled by the power and promise of new technologies. Indeed, one of the shiniest tools in the biomedical toolkit these days is the genome editing system ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.